Neurotech International Ltd

ASX:NTI (Australia)  
A$ 0.09 (0%) Apr 23
At Loss
P/B:
18.40
Market Cap:
A$ 84.40M ($ 54.74M)
Enterprise V:
A$ 79.92M ($ 51.84M)
Volume:
1.33M
Avg Vol (2M):
2.36M
Volume:
1.33M
At Loss
Avg Vol (2M):
2.36M

Business Description

Description
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.95
Interest Coverage No Debt
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 25.68
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -11.2
3-Year EPS without NRI Growth Rate 3.1
3-Year FCF Growth Rate -26

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 16.44
9-Day RSI 28.42
14-Day RSI 37
6-1 Month Momentum % 85.19
12-1 Month Momentum % 96.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.37
Quick Ratio 18.34
Cash Ratio 16.23
Days Sales Outstanding 30879

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -59.5
Shareholder Yield % -0.72

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -165020
Net Margin % -99660
FCF Margin % -85300
ROE % -86.37
ROA % -77.46
ROIC % -3218.86
ROC (Joel Greenblatt) % -3218.86
ROCE % -143.01

Financials

ASX:NTI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Neurotech International Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0.005
EPS (TTM) (A$) -0.006
Beta 1.15
Volatility % 70.76
14-Day RSI 37
14-Day ATR (A$) 0.006448
20-Day SMA (A$) 0.1027
12-1 Month Momentum % 96.08
52-Week Range (A$) 0.031 - 0.125
Shares Outstanding (Mil) 917.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neurotech International Ltd Filings

Filing Date Document Date Form
No Filing Data

Neurotech International Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Neurotech International Ltd Frequently Asked Questions

What is Neurotech International Ltd(ASX:NTI)'s stock price today?
The current price of ASX:NTI is A$0.09. The 52 week high of ASX:NTI is A$0.13 and 52 week low is A$0.03.
When is next earnings date of Neurotech International Ltd(ASX:NTI)?
The next earnings date of Neurotech International Ltd(ASX:NTI) is .
Does Neurotech International Ltd(ASX:NTI) pay dividends? If so, how much?
Neurotech International Ltd(ASX:NTI) does not pay dividend.

Press Release

Subject Date
No Press Release